World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
67
Citations
13705
World Ranking
8338
National Ranking
3761

Overview

Edward P. Acosta is affiliated with the University of Alabama at Birmingham in the United States. Their research primarily focuses on medicine, with a significant emphasis on infectious diseases, pulmonary and respiratory medicine, virology, molecular biology, and pediatrics, perinatology, and child health.

The scientist's work covers a range of topics including:

  • HIV/AIDS drug development and treatment
  • HIV research and treatment
  • HIV/AIDS research and interventions
  • HIV-related health complications and treatments
  • Cystic fibrosis research advances
  • Pharmacological effects and toxicity studies
  • Cytomegalovirus and herpesvirus research

The following are some of the recent papers by Edward P. Acosta:

  • Impact of lipid nanoparticle size on mRNA vaccine immunogenicity, 2021, Journal of Controlled Release
  • Discovery of a Novel Amino Lipid That Improves Lipid Nanoparticle Performance through Specific Interactions with mRNA, 2021, Advanced Functional Materials
  • Time to Viral Rebound After Interruption of Modern Antiretroviral Therapies, 2021, Clinical Infectious Diseases
  • Antiviral therapy: Valacyclovir Treatment of Alzheimer's Disease (VALAD) Trial: protocol for a randomised, double-blind, placebo-controlled, treatment trial, 2020, BMJ Open
  • HIV post-treatment controllers have distinct immunological and virological features, 2023, Proceedings of the National Academy of Sciences

Frequent co-authors collaborating with Edward P. Acosta include:

  • Kevin J. Ryan
  • Jennifer S. Guimbellot
  • Ellen Townley
  • David W. Kimberlin
  • Evgenia Aga

Edward P. Acosta's research has been published repeatedly in several venues, among the most frequent are:

  • UNC Libraries
  • The Journal of Infectious Diseases
  • Journal of Cystic Fibrosis
  • JAIDS Journal of Acquired Immune Deficiency Syndromes
  • American Journal of Respiratory and Critical Care Medicine

Best Publications

  • Valganciclovir for Symptomatic Congenital Cytomegalovirus Disease

    D. W. Kimberlin;P. M. Jester;P. J. Sánchez;A. Ahmed

  • Pharmacogenetics of efavirenz and central nervous system side effects: an Adult AIDS Clinical Trials Group study.

    David W Haas;Heather J Ribaudo;Richard B Kim;Camlin Tierney

  • Triple-Nucleoside Regimens versus Efavirenz-Containing Regimens for the Initial Treatment of HIV-1 Infection

    Roy M. Gulick;Roy M. Gulick;Heather J. Ribaudo;Cecilia M. Shikuma;Stephanie Lustgarten

  • Adherence-resistance relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitness.

    David R Bangsberg;Edward P Acosta;Reena Gupta;David Guzman

  • Dose-response Curve Slope Sets Class-Specific Limits on Inhibitory Potential of Anti-HIV Drugs

    Lin Shen;Susan Peterson;Ahmad R Sedaghat;Moira A McMahon

  • Pharmacokinetic and pharmacodynamic assessment of oral valganciclovir in the treatment of symptomatic congenital cytomegalovirus disease

    David W Kimberlin;Edward P Acosta;Pablo J Sánchez;Sunil Sood

  • Impact of Efavirenz on Neuropsychological Performance and Symptoms in HIV-Infected Individuals

    David B. Clifford;Scott Evans;Yijun Yang;Edward P. Acosta

  • Three- vs four-drug antiretroviral regimens for the initial treatment of HIV-1 infection: a randomized controlled trial.

    Roy M. Gulick;Heather J. Ribaudo;Cecilia M. Shikuma;Christina Lalama

  • Short-course raltegravir intensification does not reduce persistent low-level viremia in patients with HIV-1 suppression during receipt of combination antiretroviral therapy

    D. McMahon;J. Jones;A. Wiegand;S. J. Gange

  • Pharmacogenetics of Plasma Efavirenz Exposure after Treatment Discontinuation: An Adult AIDS Clinical Trials Group Study

    Heather J. Ribaudo;David W. Haas;Camlin Tierney;Richard B. Kim

  • Indinavir concentrations and antiviral effect.

    Edward P. Acosta;Keith Henry;Leslie Baken;Linda M. Page

  • Preexisting Resistance to Nonnucleoside Reverse-Transcriptase Inhibitors Predicts Virologic Failure of an Efavirenz-Based Regimen in Treatment-Naive HIV-1–Infected Subjects

    Daniel R Kuritzkes;Christina M Lalama;Heather J Ribaudo;Michelle Marcial

  • Clinical Trial of the Anti-PD-L1 Antibody BMS-936559 in HIV-1 Infected Participants on Suppressive Antiretroviral Therapy

    Ronald J Bosch;Justin Ritz;Jason M Hataye

  • Resveratrol induces cell cycle arrest and apoptosis with docetaxel in prostate cancer cells via a p53/ p21 WAF1/CIP1 and p27 KIP1 pathway

    Santosh Kumar Singh;Saswati Banerjee;Edward P. Acosta;James W. Lillard

  • Efficacy of a nucleoside-sparing regimen of darunavir/ritonavir plus raltegravir in treatment-naive HIV-1-infected patients (ACTG A5262).

    Babafemi Taiwo;Lu Zheng;Sebastien Gallien;Roy M. Matining

  • The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Posttreatment Controllers Identified From 14 Clinical Studies

    Golnaz Namazi;Jesse M Fajnzylber;Evgenia Aga;Ronald J Bosch

  • Effectiveness of a city-wide program to prevent mother-to-child HIV transmission in Lusaka, Zambia

    Jeffrey S. A. Stringer;Moses Sinkala;Moses Sinkala;Moses Sinkala;Courtney C. Maclean;Jens Levy;Jens Levy

  • Effect of CYP2B6, ABCB1, and CYP3A5 Polymorphisms on Efavirenz Pharmacokinetics and Treatment Response: An AIDS Clinical Trials Group Study

    Heather J. Ribaudo;Huan Liu;Matthias Schwab;Elke Schaeffeler

  • Gender differences in human pharmacokinetics and pharmacodynamics.

    Courtney V. Fletcher;Edward P. Acosta;Edward P. Acosta;Jill M. Strykowski;Jill M. Strykowski

  • Valganciclovir for Symptomatic Congenital Cytomegalovirus Disease

    David W. Kimberlin;Penelope M. Jester;Pablo J. Sánchez;Amina Ahmed

Frequent Co-Authors

Roy M. Gulick
Roy M. Gulick Cornell University
David W. Haas
David W. Haas Vanderbilt University Medical Center
Daniel R. Kuritzkes
Daniel R. Kuritzkes Brigham and Women's Hospital
Andrew Wiznia
Andrew Wiznia Albert Einstein College of Medicine
David W. Kimberlin
David W. Kimberlin University of Alabama at Birmingham
Joseph J. Eron
Joseph J. Eron University of North Carolina at Chapel Hill
Sten H. Vermund
Sten H. Vermund Yale University
Robert L. Goldenberg
Robert L. Goldenberg Columbia University
Keith Henry
Keith Henry Hennepin County Medical Center
Richard J. Whitley
Richard J. Whitley University of Alabama at Birmingham

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Biology and Biochemistry in the USA opens the door to a wide range of rewarding online degree programs and career options in healthcare and life sciences. Many students interested in these fields consider programs that expand their qualifications or help them transition into new roles within health and science sectors.

For those with a nursing background, enrolling in the easiest rn to bsn program can lead to greater clinical opportunities and advancement. Others looking to move into management roles often pursue the fastest online master's in healthcare management for a quick pathway to leadership positions.

If mental health is your passion, specialized degrees like psychiatric np programs offer focused training and faster entry into high-demand roles. Additionally, for those interested in dietetics and wellness, pursuing an accelerated nutrition degree online can rapidly prepare you for careers in nutritional science and public health.

These flexible online programs make it easier for students and professionals in Biology and Biochemistry to find pathways tailored to their personal interests and career ambitions.

Best Scientists Citing Edward P. Acosta

Trending Scientists

Recently Published Articles